American Health announced that the company held the 25th meeting of the 9th board of directors on July 17, 2026 to review and pass the “Proposal on Termination of Issuance of Shares to Purchase Assets and Related Transactions and Withdrawal of Application Documents”, agreed that the company would terminate the issuance of shares to purchase assets and related transactions and withdraw the application documents for this transaction from the Shenzhen Stock Exchange. On July 24, 2026, the company received the Shenzhen Stock Exchange's “Decision to Terminate the Review of the Application for Asset Purchase by American Health Industry Holdings Co., Ltd.” (Shenzhen Securities Review (2026) No. 233). According to the relevant provisions of Section 52 of the “Shenzhen Stock Exchange Listed Company Significant Asset Reorganization Review Rules”, the Shenzhen Stock Exchange decided to terminate the review of the application for the company to issue shares to purchase assets.

American Health announced that the company held the 25th meeting of the 9th board of directors on July 17, 2026 to review and pass the “Proposal on Termination of Issuance of Shares to Purchase Assets and Related Transactions and Withdrawal of Application Documents”, agreed that the company would terminate the issuance of shares to purchase assets and related transactions and withdraw the application documents for this transaction from the Shenzhen Stock Exchange. On July 24, 2026, the company received the Shenzhen Stock Exchange's “Decision to Terminate the Review of the Application for Asset Purchase by American Health Industry Holdings Co., Ltd.” (Shenzhen Securities Review (2026) No. 233). According to the relevant provisions of Section 52 of the “Shenzhen Stock Exchange Listed Company Significant Asset Reorganization Review Rules”, the Shenzhen Stock Exchange decided to terminate the review of the application for the company to issue shares to purchase assets.